Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history

Hermaleigh Townsley, Joshua Gahir, View ORCID ProfileTimothy W Russell, Edward J Carr, Matala Dyke, Lorin Adams, Murad Miah, Bobbi Clayton, Callie Smith, Mauro Miranda, Harriet V Mears, Chris Bailey, James RM Black, Ashley S Fowler, Margaret Crawford, Katalin Wilkinson, Matthew Hutchinson, Ruth Harvey, Nicola O’Reilly, Gavin Kelly, Robert Goldstone, Rupert Beale, Padmasayee Papineni, Tumena Corrah, Richard Gilson, Simon Caidan, View ORCID ProfileJerome Nicod, Steve Gamblin, View ORCID ProfileGeorge Kassiotis, Vincenzo Libri, Bryan Williams, Sonia Gandhi, Adam J Kucharski, Charles Swanton, View ORCID ProfileDavid LV Bauer, View ORCID ProfileEmma C Wall
doi: https://doi.org/10.1101/2022.07.07.22277367
Hermaleigh Townsley
1The Francis Crick Institute, 1 Midland Road, London, UK
2National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua Gahir
1The Francis Crick Institute, 1 Midland Road, London, UK
2National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy W Russell
3Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy W Russell
Edward J Carr
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matala Dyke
1The Francis Crick Institute, 1 Midland Road, London, UK
2National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorin Adams
4Worldwide Influenza Centre, The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murad Miah
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bobbi Clayton
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Callie Smith
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Miranda
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harriet V Mears
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Bailey
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James RM Black
1The Francis Crick Institute, 1 Midland Road, London, UK
5University College London, Gower Street, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley S Fowler
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Crawford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katalin Wilkinson
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Hutchinson
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Harvey
1The Francis Crick Institute, 1 Midland Road, London, UK
4Worldwide Influenza Centre, The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola O’Reilly
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Kelly
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Goldstone
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupert Beale
1The Francis Crick Institute, 1 Midland Road, London, UK
5University College London, Gower Street, London
9Genotype-to-Phenotype UK National Virology Consortium (G2P-UK)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Padmasayee Papineni
6London Northwest University Healthcare NHS Trust, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tumena Corrah
6London Northwest University Healthcare NHS Trust, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Gilson
7Camden and North West London NHS Community Trust, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Caidan
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerome Nicod
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jerome Nicod
Steve Gamblin
1The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Kassiotis
1The Francis Crick Institute, 1 Midland Road, London, UK
8Department of Infectious Disease, St Mary’s Hospital, Imperial College London, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for George Kassiotis
Vincenzo Libri
2National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK
4Worldwide Influenza Centre, The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Williams
2National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK
4Worldwide Influenza Centre, The Francis Crick Institute, 1 Midland Road, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Gandhi
1The Francis Crick Institute, 1 Midland Road, London, UK
5University College London, Gower Street, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J Kucharski
3Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Swanton
1The Francis Crick Institute, 1 Midland Road, London, UK
5University College London, Gower Street, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David LV Bauer
1The Francis Crick Institute, 1 Midland Road, London, UK
9Genotype-to-Phenotype UK National Virology Consortium (G2P-UK)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David LV Bauer
  • For correspondence: david.bauer{at}crick.ac.uk emma.wall{at}crick.ac.uk
Emma C Wall
1The Francis Crick Institute, 1 Midland Road, London, UK
2National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emma C Wall
  • For correspondence: david.bauer{at}crick.ac.uk emma.wall{at}crick.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background SARS-CoV-2 variant Omicron rapidly evolved over 2022, causing three waves of infection due to sub-variants BA.1, BA.2 and BA.4/5. We sought to characterise symptoms and viral loads over the course of COVID-19 infection with these sub-variants in otherwise-healthy, vaccinated, non-hospitalised adults, and compared data to infections with the preceding Delta variant of concern (VOC).

Methods In a prospective, observational cohort study, healthy vaccinated UK adults who reported a positive PCR or lateral flow test, self-swabbed on alternate days until day 10. We compared symptoms and viral load trajectories between infections caused by VOCs Delta and Omicron (sub-variants BA.1, BA.2 and BA.4/5), and tested for relationships between vaccine dose, symptoms and PCR Ct value as a proxy for viral load.

Results 555 infection episodes were reported among 483 participants. Across VOCs, symptom burden and duration were similar, however symptom profiles differed among infections caused by Delta compared to Omicron sub-variants; symptoms of all Omicron sub-variants BA.1, BA.2 and BA.4/5 were very similar. Anosmia was reported in 7-13% of participants with Omicron sub-variants, compared to 25/60 (42%) with Delta infection (P= 1.31e-08 or 1.03e-05 or 5.63e-05; χ2 test d2+Delta vs. Omicron BA.1 or vs. BA.2, or BA.5, respectively), fever was more common with Omicron BA.5 (30/55, 55%) than Delta (20/60, 33%) (p 0.03). Amongst infections with all Omicron sub-variants, symptoms of coryza, fatigue, cough and myalgia predominated. Viral load trajectories and peaks did not differ between Delta, and Omicron, irrespective of symptom severity (including asymptomatic participants), VOC or vaccination status. Ct values were negatively associated with time since vaccination in participants infected with BA.1; however, this trend was not observed in BA.2/BA.4/5 infections.

Conclusion Our study emphasises both the changing symptom profile of COVID-19 infections in the Omicron era, and ongoing transmission risk of Omicron sub-variants in vaccinated adults.

Trial registration NCT04750356

Competing Interest Statement

CSw reports interests unrelated to this Correspondence: grants from BMS, Ono-Pharmaceuticals, Boehringer-Ingelheim, Roche-Ventana, Pfizer and Archer Dx, unrelated to this Correspondence; personal fees from Genentech, Sarah Canon Research Institute, Medicxi, Bicycle Therapeutics, GRAIL, Amgen, AstraZeneca, BMS, Illumina, GlaxoSmithKline, MSD, and Roche-Ventana, unrelated to this Correspondence; and stock options from Apogen Biotech, Epic Biosciences, GRAIL, and Achilles Therapeutics, unrelated to this Correspondence. DLVB reports grants from AstraZeneca unrelated to this Correspondence. All other authors declare no competing interests.

Funding Statement

This work was supported by UCLH/UCL who received a proportion of funding from the National Institute for Health Research (NIHR) University College London Hospitals Department of Health NIHR Biomedical Research Centre (BRC). EW VL and BW are supported by the Centre funding scheme. This work was supported jointly by the BRC and core funding from the Francis Crick Institute which receives its funding from Cancer Research UK the UK Medical Research Council and the Wellcome Trust. This research was funded in whole or in part by the Wellcome Trust. For the purpose of Open Access the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. DLVB is additionally supported by the Genotype to Phenotype National Virology Consortium via UK Research and Innovation and the UK Medical Research Council and TWR and AJK are additionally supported by the Wellcome Trust.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Legacy study was approved by London Camden and Kings Cross Health Research Authority Research and Ethics committee (IRAS number 286469)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Senior authors: Sonia Gandhi, Adam J Kucharski, Charles Swanton, Emma C Wall, David LV Bauer

  • Addition of symptoms for Omicron BA.5 infections, with associated viral kinetic data. All analyses updated using the same code as the previous version, to include BA.5 as a comparator for all Omicron sub-VOC studied with Delta

Data Availability

All data produced in the present work are contained in the manuscript and will be made openly available online after peer review

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy W Russell, Edward J Carr, Matala Dyke, Lorin Adams, Murad Miah, Bobbi Clayton, Callie Smith, Mauro Miranda, Harriet V Mears, Chris Bailey, James RM Black, Ashley S Fowler, Margaret Crawford, Katalin Wilkinson, Matthew Hutchinson, Ruth Harvey, Nicola O’Reilly, Gavin Kelly, Robert Goldstone, Rupert Beale, Padmasayee Papineni, Tumena Corrah, Richard Gilson, Simon Caidan, Jerome Nicod, Steve Gamblin, George Kassiotis, Vincenzo Libri, Bryan Williams, Sonia Gandhi, Adam J Kucharski, Charles Swanton, David LV Bauer, Emma C Wall
medRxiv 2022.07.07.22277367; doi: https://doi.org/10.1101/2022.07.07.22277367
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy W Russell, Edward J Carr, Matala Dyke, Lorin Adams, Murad Miah, Bobbi Clayton, Callie Smith, Mauro Miranda, Harriet V Mears, Chris Bailey, James RM Black, Ashley S Fowler, Margaret Crawford, Katalin Wilkinson, Matthew Hutchinson, Ruth Harvey, Nicola O’Reilly, Gavin Kelly, Robert Goldstone, Rupert Beale, Padmasayee Papineni, Tumena Corrah, Richard Gilson, Simon Caidan, Jerome Nicod, Steve Gamblin, George Kassiotis, Vincenzo Libri, Bryan Williams, Sonia Gandhi, Adam J Kucharski, Charles Swanton, David LV Bauer, Emma C Wall
medRxiv 2022.07.07.22277367; doi: https://doi.org/10.1101/2022.07.07.22277367

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)